More Than Hair Loss: Current and Emerging Therapies for Alopecia Areata

This activity is part of a series


Nekma Meah, MBChB, MRCP (UK), MRCP (Derm), FACD
Consultant Dermatologist, Blackburn, UK
Honorary Secretary, British Hair and Nail Society
Consultant Dermatologist, BMI The Beardwood Hospital, Blackburn, UK
Nekma Meah, MBChB, MRCP (UK), MRCP (Derm), FACD

Dr Nekma Meah is a Consultant Dermatologist with a specialist interest in the management of hair and scalp disorders. She has undertaken an international hair fellowship under Professor Rodney Sinclair in Australia in 2017 and published extensively including co-leading The Alopecia Areata Consensus of Experts (ACE) study and the Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS) project. She runs the specialist hair clinic at St Helens and Knowsley NHS Trust and is currently the Honorary Secretary of the British Hair and Nail Society.

She obtained her MBChB from the University of Manchester in 2007 and undertook her junior doctor training in the West Midlands before entering the specialist dermatology programme in Liverpool. She qualified as a Consultant Dermatologist in 2017.

Dr Meah is passionate about dermatology, teaching and research and helped to establish the BHNS national hair and nail teaching day for dermatology trainees in 2021. She is Honorary Clinical Lecturer at The University of Manchester and serves on the steering committee for the global COVID-19 alopecia registry – SECURE alopecia.

Dmitri Wall, MB BCh BAO, MRCP (UK), MSc
Assistant Professor, University College Dublin School of Medicine, Dublin, Ireland
Assistant Professor, Charles Institute of Dermatology, University College Dublin School of Medicine
Hair Restoration Blackrock, Dublin
Dmitri Wall, MB BCh BAO, MRCP (UK), MSc

Dr. Dmitri Wall is a consultant Dermatologist with a special interest in hair disorders. A graduate of University College Dublin, Ireland, he completed higher specialist training with the Royal College of Physicians of Ireland before undertaking an international hair fellowship in Melbourne, Australia with Professor Rodney Sinclair. Since his return in 2019, he has worked as a consultant in St James’s Hospital, Dublin, Ireland and Hair Restoration Blackrock, Dublin, Ireland.

Dr. Wall is Assistant Professor in the Charles Institute of Dermatology, University College Dublin School of Medicine. He is actively engaged in both basic scientific and clinical research with national and international colleagues, focusing primarily on hair and scalp disorders and has published in a number of journals. He is a member of the scientific committee of the Irish Association of Dermatologists (IAD) and is also a member of the British Association of Dermatologists, European Academy of Dermatology and Venereology, International Society of Dermatology, Australasian Hair and Wool Research Society and the International Society of Hair Restoration Surgery.

Dr. Wall also has a special interest in health informatics. He has obtained an MSc through Trinity College Dublin, Ireland and has worked with Professor Alan Irvine and the Irish Skin Foundation charity, over the last decade, to develop the not-for-profit charity National and International Skin Registries (NISR), that develops international patient registries, including a role in the development of the emerging global network of patient registries for alopecia areata (GRASS) with a view to improving international collaboration and facilitating re-use of comparable clinical data.

Most recently Dr. Wall has worked with colleagues internationally to establish two global, physician-entered, anonymized patient registries, SECURE-AD (Alan Irvine – Ireland, Carsten Flohr – United Kingdom, Phyllis Spuls – The Netherlands) and SECURE – Alopecia (Rodney Sinclair – Australia; Nekma Meah – United Kingdom; Katherine York – South Africa; Alan Irvine – Ireland), to record and analyze outcomes of COVID-19 positive patients suffering from atopic dermatitis and all forms of alopecia, respectively.

Statement of Need

Current treatments for alopecia areata (AA) include topical and systemic anti-inflammatories, immunosuppressants, and immunosensitizers depending on patient age and disease severity. Because these therapeutic options produce variable clinical outcomes, each case must be approached on a customized, individual basis. A developing pipeline of immunomodulating agents (e.g. Janus kinase inhibitors) offers promise to bridge significant treatment gaps left by current therapies. It is important that clinicians who treat patients with AA elevate their knowledge of both current and emerging therapies for AA in order to enhance best practices and patient outcomes.

Join us for the third installment of this three-part virtual Journal Club series, More Than Hair Loss: Current and Emerging Therapies for Alopecia Areata, as Drs. Nekma Meah and Dmitri Wall explore the evolving landscape of AA treatment.

Learning Objectives

At the end of this CME/CE activity, participants should be able to review current and emerging treatments for AA.

Financial Support

Supported by an educational grant from Pfizer Inc.

Target Audience

Physicians, PAs, and nurse practitioners specializing in dermatology, allergy/immunology, general practice, and/or pediatrics located outside of the United States

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME)

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC)

This activity is designated for 1.0 contact hour.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit  from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.


CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until the expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.


Through a mutual recognition agreement between the AMA and the UEMS-EACCME, European physicians completing an e-learning activity from a US-based ACCME-accredited CME provider can use AMA PRA Category 1 Credit™ toward their credit requirements. CME Outfitters is based in Radnor, Pennsylvania, USA. Please retain your certificate as proof of completion.


Through a mutual recognition agreement between the AMA and the DHP, physicians licensed in Qatar completing an activity from a US-based ACCME-accredited CME provider can use ACCME AMA PRA Category 1 Credits toward their credit requirements.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Meah reports no financial relationships.

Dr. Wall reports the following financial relationships:

Consultant: Bristol Myers Squibb and Pfizer Inc. (on behalf of the National and International Skin Registry)

Grants/Research Support: Janssen Global Services, LLC and Pfizer Inc.

Other: National and International Skin Registry Solutions (Charity)

The following peer reviewer and CME Outfitters staff report no financial relationships:

Shirley Michelle Franks, MSN, APRN, FNP-BC (peer reviewer)

Kellie Busby, PharmD (planning committee)

Susan Perry (planning committee)

Susan H. Yarbrough, CHCP (planning committee)

Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Additional Formats

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).



More Than Hair Loss: Current and Emerging Therapies for Alopecia Areata
Event Date: 06/16/2022 at 8:00 am